Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Discontinuation Associated With Perioperative Toxicity of FLOT Versus XELOX Chemotherapy in Patient With Resectable Gastric Cancer; Phase 2

NCT04937738 is registered in ClinicalTrials.gov with Ukrainian Society of Clinical Oncology as lead sponsor.

NCT NCT04937738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04937738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Discontinuation Associated With Perioperative Toxicity of FLOT Versus XELOX Chemotherapy in Patient With Resectable Gastric Cancer; Phase 2
Lead sponsor
Ukrainian Society of Clinical Oncology
Phase
Phase 2
Overall status
Terminated
Start date
July 21, 2021
Completion date
February 1, 2023
Enrollment
69 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer